Marpai (MRAI) Competitors $0.99 -0.26 (-20.72%) As of 03/27/2025 03:36 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock MRAI vs. TOI, ENZ, CCM, OPGN, BRTX, KDLY, MGRX, SSY, OTRK, and BGLCShould you be buying Marpai stock or one of its competitors? The main competitors of Marpai include Oncology Institute (TOI), Enzo Biochem (ENZ), Concord Medical Services (CCM), OpGen (OPGN), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Ontrak (OTRK), and BioNexus Gene Lab (BGLC). These companies are all part of the "healthcare" industry. Marpai vs. Oncology Institute Enzo Biochem Concord Medical Services OpGen BioRestorative Therapies Kindly MD Mangoceuticals SunLink Health Systems Ontrak BioNexus Gene Lab Marpai (NASDAQ:MRAI) and Oncology Institute (NASDAQ:TOI) are both small-cap business services companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, community ranking, earnings and dividends. Do insiders and institutionals have more ownership in MRAI or TOI? 49.8% of Marpai shares are owned by institutional investors. Comparatively, 36.9% of Oncology Institute shares are owned by institutional investors. 61.3% of Marpai shares are owned by company insiders. Comparatively, 9.5% of Oncology Institute shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, MRAI or TOI? Marpai has a beta of 5.02, suggesting that its stock price is 402% more volatile than the S&P 500. Comparatively, Oncology Institute has a beta of 0.41, suggesting that its stock price is 59% less volatile than the S&P 500. Which has stronger valuation and earnings, MRAI or TOI? Marpai has higher earnings, but lower revenue than Oncology Institute. Oncology Institute is trading at a lower price-to-earnings ratio than Marpai, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMarpai$34.87M0.41-$28.75M-$2.64-0.38Oncology Institute$393.41M0.21-$83.07M-$0.71-1.56 Does the media prefer MRAI or TOI? In the previous week, Oncology Institute had 9 more articles in the media than Marpai. MarketBeat recorded 13 mentions for Oncology Institute and 4 mentions for Marpai. Marpai's average media sentiment score of 0.35 beat Oncology Institute's score of 0.03 indicating that Marpai is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Marpai 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Oncology Institute 1 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Does the MarketBeat Community prefer MRAI or TOI? Oncology Institute received 2 more outperform votes than Marpai when rated by MarketBeat users. CompanyUnderperformOutperformMarpaiOutperform Votes266.67% Underperform Votes133.33% Oncology InstituteOutperform Votes466.67% Underperform Votes233.33% Is MRAI or TOI more profitable? Oncology Institute has a net margin of -17.63% compared to Marpai's net margin of -85.70%. Marpai's return on equity of 0.00% beat Oncology Institute's return on equity.Company Net Margins Return on Equity Return on Assets Marpai-85.70% N/A -100.23% Oncology Institute -17.63%-186.83%-34.58% SummaryMarpai beats Oncology Institute on 8 of the 14 factors compared between the two stocks. Remove Ads Get Marpai News Delivered to You Automatically Sign up to receive the latest news and ratings for MRAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MRAI vs. The Competition Export to ExcelMetricMarpaihealth & allied services, not elsewhere classified IndustryBusiness SectorNASDAQ ExchangeMarket Cap$14.35M$2.03B$7.25B$8.06BDividend YieldN/A7.11%2.53%4.01%P/E Ratio-0.3815.8530.2919.03Price / Sales0.413.59158.1593.17Price / CashN/A9.3231.5134.64Price / Book-0.584.324.884.33Net Income-$28.75M$87.49M$195.43M$247.06M7 Day Performance4.32%-2.46%0.75%-0.37%1 Month Performance8.90%-4.13%-2.83%-3.85%1 Year Performance-59.39%-26.67%5.15%1.27% Marpai Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MRAIMarpai1.9457 of 5 stars$0.99-20.7%$6.00+505.4%-52.4%$14.35M$34.87M-0.38150News CoverageGap DownHigh Trading VolumeTOIOncology Institute0.1988 of 5 stars$0.70+7.4%N/A-39.7%$52.97M$378.93M-0.90660Earnings ReportENZEnzo Biochem0.5394 of 5 stars$0.47-4.7%N/A-66.8%$24.76M$30.31M0.00520CCMConcord Medical Services0.5394 of 5 stars$4.53+2.1%N/A-27.0%$19.28M$471.70M0.00970Short Interest ↑Gap DownOPGNOpGenN/A$1.75+52.2%N/A-52.6%$14.62M$2.67M0.00100Analyst ForecastGap UpHigh Trading VolumeBRTXBioRestorative Therapies3.6952 of 5 stars$1.67-5.6%$18.00+977.8%+30.7%$11.56M$377,000.00-1.097Short Interest ↓News CoverageGap UpKDLYKindly MDN/A$1.57+4.7%N/AN/A$9.38M$2.88M0.00N/APositive NewsGap UpMGRXMangoceuticals0.6022 of 5 stars$3.64-6.9%N/A-95.2%$9.05M$755,000.00-0.633Earnings ReportSSYSunLink Health SystemsN/A$0.99-1.1%N/A+45.9%$6.94M$31.23M7.041,376Analyst ForecastNews CoverageOTRKOntrak3.0076 of 5 stars$1.47+2.1%$45.00+2,961.2%-82.9%$6.20M$11.24M-0.14250Gap UpBGLCBioNexus Gene Lab1.1669 of 5 stars$0.31-11.7%N/A-57.3%$5.55M$9.26M0.0030Short Interest ↓Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies Oncology Institute Competitors Enzo Biochem Competitors Concord Medical Services Competitors OpGen Competitors BioRestorative Therapies Competitors Kindly MD Competitors Mangoceuticals Competitors SunLink Health Systems Competitors Ontrak Competitors BioNexus Gene Lab Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MRAI) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marpai, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marpai With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MRAI Stock Free MRAI Stock Alerts